HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B.

AbstractBACKGROUND:
Mucopolysaccharidosis (MPS) IIIB (Sanfilippo Syndrome type B) is caused by a deficiency in the lysosomal enzyme N-acetyl-glucosaminidase (Naglu). Children with MPS IIIB develop disturbances of sleep, activity levels, coordination, vision, hearing, and mental functioning culminating in early death. The murine model of MPS IIIB demonstrates lysosomal distention in multiple tissues, a shortened life span, and behavioral changes.
PRINCIPAL FINDINGS:
To more thoroughly assess MPS IIIB in mice, alterations in circadian rhythm, activity level, motor function, vision, and hearing were tested. The suprachiasmatic nucleus (SCN) developed pathologic changes and locomotor analysis showed that MPS IIIB mice start their daily activity later and have a lower proportion of activity during the night than wild-type controls. Rotarod assessment of motor function revealed a progressive inability to coordinate movement in a rocking paradigm. Purkinje cell counts were significantly reduced in the MPS IIIB animals compared to age matched controls. By electroretinography (ERG), MPS IIIB mice had a progressive decrease in the amplitude of the dark-adapted b-wave response. Corresponding pathology revealed shortening of the outer segments, thinning of the outer nuclear layer, and inclusions in the retinal pigmented epithelium. Auditory-evoked brainstem responses (ABR) demonstrated progressive hearing deficits consistent with the observed loss of hair cells in the inner ear and histologic abnormalities in the middle ear.
CONCLUSIONS/SIGNIFICANCE:
The mouse model of MPS IIIB has several quantifiable phenotypic alterations and is similar to the human disease. These physiologic and histologic changes provide insights into the progression of this disease and will serve as important parameters when evaluating various therapies.
AuthorsCoy D Heldermon, Anne K Hennig, Kevin K Ohlemiller, Judith M Ogilvie, Erik D Herzog, Annalisa Breidenbach, Carole Vogler, David F Wozniak, Mark S Sands
JournalPloS one (PLoS One) Vol. 2 Issue 8 Pg. e772 (Aug 22 2007) ISSN: 1932-6203 [Electronic] United States
PMID17712420 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetylglucosaminidase
Topics
  • Acetylglucosaminidase (deficiency)
  • Animals
  • Behavior, Animal (physiology)
  • Cerebellum (cytology, pathology)
  • Child
  • Circadian Rhythm (physiology)
  • Disease Models, Animal
  • Ear, Inner (pathology)
  • Ear, Middle (pathology)
  • Electroretinography
  • Evoked Potentials, Auditory (physiology)
  • Female
  • Hearing (physiology)
  • Humans
  • Lysosomes (enzymology, pathology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Motor Activity (physiology)
  • Mucopolysaccharidosis III (enzymology, pathology, physiopathology)
  • Phenotype
  • Retina (pathology)
  • Rotarod Performance Test
  • Suprachiasmatic Nucleus (cytology, pathology)
  • Vision, Ocular (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: